Category - Pharma Industry News
PureTech launches phase II ‘long COVID’ drug trial
Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM
Bayer strengthens cell and gene therapy focus with new platform
Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM
US secures 650,000 additional doses of Lilly’s COVID-19 antibody
WHO set to review Pfizer/BioNTech COVID-19 vaccine for emergency use listing
Janssen buys rights to Hemera’s eye disease gene therapy candidate
AbbVie partners with Frontier Medicines on protein degrader development